QQQ   423.41 (-0.57%)
AAPL   167.04 (-0.57%)
MSFT   404.27 (-1.84%)
META   501.80 (+1.54%)
GOOGL   156.01 (+0.35%)
AMZN   179.22 (-1.14%)
TSLA   149.93 (-3.55%)
NVDA   846.71 (+0.76%)
AMD   155.08 (+0.69%)
NIO   4.00 (+2.30%)
BABA   68.88 (+0.09%)
T   16.33 (+1.30%)
F   12.06 (+0.17%)
MU   111.93 (-3.78%)
GE   152.94 (-1.75%)
CGC   7.83 (+20.65%)
DIS   112.43 (-0.45%)
AMC   2.92 (-2.01%)
PFE   25.39 (-0.12%)
PYPL   62.10 (-1.83%)
XOM   118.52 (-0.09%)
QQQ   423.41 (-0.57%)
AAPL   167.04 (-0.57%)
MSFT   404.27 (-1.84%)
META   501.80 (+1.54%)
GOOGL   156.01 (+0.35%)
AMZN   179.22 (-1.14%)
TSLA   149.93 (-3.55%)
NVDA   846.71 (+0.76%)
AMD   155.08 (+0.69%)
NIO   4.00 (+2.30%)
BABA   68.88 (+0.09%)
T   16.33 (+1.30%)
F   12.06 (+0.17%)
MU   111.93 (-3.78%)
GE   152.94 (-1.75%)
CGC   7.83 (+20.65%)
DIS   112.43 (-0.45%)
AMC   2.92 (-2.01%)
PFE   25.39 (-0.12%)
PYPL   62.10 (-1.83%)
XOM   118.52 (-0.09%)
QQQ   423.41 (-0.57%)
AAPL   167.04 (-0.57%)
MSFT   404.27 (-1.84%)
META   501.80 (+1.54%)
GOOGL   156.01 (+0.35%)
AMZN   179.22 (-1.14%)
TSLA   149.93 (-3.55%)
NVDA   846.71 (+0.76%)
AMD   155.08 (+0.69%)
NIO   4.00 (+2.30%)
BABA   68.88 (+0.09%)
T   16.33 (+1.30%)
F   12.06 (+0.17%)
MU   111.93 (-3.78%)
GE   152.94 (-1.75%)
CGC   7.83 (+20.65%)
DIS   112.43 (-0.45%)
AMC   2.92 (-2.01%)
PFE   25.39 (-0.12%)
PYPL   62.10 (-1.83%)
XOM   118.52 (-0.09%)
QQQ   423.41 (-0.57%)
AAPL   167.04 (-0.57%)
MSFT   404.27 (-1.84%)
META   501.80 (+1.54%)
GOOGL   156.01 (+0.35%)
AMZN   179.22 (-1.14%)
TSLA   149.93 (-3.55%)
NVDA   846.71 (+0.76%)
AMD   155.08 (+0.69%)
NIO   4.00 (+2.30%)
BABA   68.88 (+0.09%)
T   16.33 (+1.30%)
F   12.06 (+0.17%)
MU   111.93 (-3.78%)
GE   152.94 (-1.75%)
CGC   7.83 (+20.65%)
DIS   112.43 (-0.45%)
AMC   2.92 (-2.01%)
PFE   25.39 (-0.12%)
PYPL   62.10 (-1.83%)
XOM   118.52 (-0.09%)
NASDAQ:CHNA

Loncar China Biopharma ETF (CHNA) Price, Holdings, & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$13.53
$13.53
50-Day Range
$13.53
$14.77
52-Week Range
$13.35
$22.89
Volume
100 shs
Average Volume
538 shs
Market Capitalization
$3.79 million
Assets Under Management
$3.74 million
Dividend Yield
0.44%
Net Expense Ratio
0.79%
CHNA stock logo

About Loncar China Biopharma ETF (NASDAQ:CHNA)

The Loncar China BioPharma ETF (CHNA) is an exchange-traded fund that is based on the Loncar China BioPharma index. The fund tracks a tier-weighted index of companies directly involved in the growth of Chinas pharmaceutical and biotech industry. CHNA was launched on Aug 14, 2018 and is managed by Loncar.

CHNA ETF News Headlines

China Southern CSI Cmunctn Srvcs ETF (159511)
Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!
Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.
This ETF Has Depth Needed for China Rebound
China Bans Export of Rare Earths Processing Technologies
China Universal Nasdaq 100 ETF (QDII) (159660)
Amundi MSCI China A II ETF (C024)
Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!
Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.
2823 ETF Stock Price History
See More Headlines
Receive CHNA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Loncar China Biopharma ETF and its competitors with MarketBeat's FREE daily newsletter.

Fund Details

Issuer
Exchange Traded Concepts
Fund Name
Loncar China Biopharma ETF
Tax Classification
Regulated Investment Company
Current Symbol
NASDAQ:CHNA
Inception Date
8/14/2018
Fund Manager
Denise M. Krisko, Habib Moudachirou
Web
N/A

Fund Focus

Asset Class
Equity
Benchmark
Loncar China BioPharma Index
Category
Sector
Focus
Health Care
Development Level
Emerging Markets
Region
Asia-Pacific
Number of Holdings
89

Fund Statistics

Assets Under Management
$3.74 million
Average Daily Volume
$1,200.80
Discount/Premium
-0.06%

Administrator, Advisor and Custodian

Administrator
U.S. Bancorp Fund Services, LLC
Advisor
Exchange Traded Concepts, LLC
Custodian
U.S. Bank, N.A.
Distributor
Quasar Distributors, LLC
Transfer Agent
U.S. Bank, N.A.
Trustee
N/A
Lead Market Maker
GTS

Miscellaneous

Beta
0.67
Creation Unit
50,000
Creation Fee
$750.00
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Loncar China Biopharma ETF Expenses

TypeCHNAHealth Care ETFsEquity ETFsNASDAQ ETFsAll ETFs
Management Fee0.79%0.56%0.54%0.48%0.51%
Other Expenses0.00%0.40%0.54%0.34%0.58%
Total Expense0.79%0.72%0.70%0.58%0.70%
Fee Waiver0.00%-0.53%-0.55%-0.22%-0.57%
Net Expense0.79%0.60%0.60%0.54%0.58%

Loncar China Biopharma ETF (CHNA) Holdings

Top 10 CHNA Holdings

  • AIM Vaccine Co Ltd Class H
    Holding Weight: 4.27%
  • Legend Biotech(NASDAQ:LEGN)
    Holding Weight: 3.11%
  • Sinopharm Group Co Ltd
    Holding Weight: 2.54%
  • Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H
    Holding Weight: 2.36%
  • Wuxi AppTec Co Ltd
    Holding Weight: 2.24%
  • BeiGene(NASDAQ:BGNE)
    Holding Weight: 2.17%
  • Hansoh Pharmaceutical Group Co Ltd
    Holding Weight: 2.12%
  • Sino Biopharmaceutical Ltd
    Holding Weight: 2.12%
  • Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Class H
    Holding Weight: 2.05%
  • Shanghai Pharmaceuticals Holding Co Ltd Class H
    Holding Weight: 2.04%

CHNA ETF - Frequently Asked Questions

How often does Loncar China Biopharma ETF pay dividends? What is the dividend yield for Loncar China Biopharma ETF?

Loncar China Biopharma ETF announced an annual dividend on Friday, October 13th. Shareholders of record on Tuesday, October 17th will be paid a dividend of $0.0674 per share on Wednesday, October 18th. The ex-dividend date is Monday, October 16th.
Read our dividend analysis for CHNA
.

What does CHNA invest in?

Loncar China Biopharma ETF is a equity fund issued by Exchange Traded Concepts. CHNA focuses on health care investments and follows the Loncar China BioPharma Index. The fund's investments total to approximately $3.74 million assets under management.

What stocks does Loncar China Biopharma ETF hold?

CHNA invests in 89 holdings. Some of the stocks in their portfolio include Legend Biotech (LEGN), BeiGene (BGNE), HUTCHMED (HCM), Zai Lab (ZLAB) and LianBio (LIAN).

What is the management fee for Loncar China Biopharma ETF?

Loncar China Biopharma ETF's management fee is 0.79% and has no other recorded expenses or fee waivers. The net expense ratio for CHNA is 0.79%.

What other stocks do shareholders of Loncar China Biopharma ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Loncar China Biopharma ETF investors own include Baidu (BIDU), Salesforce (CRM), Capcom (CCOEY), Alibaba Group (BABA), Activision Blizzard (ATVI), ArcBest (ARCB), Advanced Micro Devices (AMD) and Analog Devices (ADI).

This page (NASDAQ:CHNA) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners